Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo

Journal of Clinical Investigation

Volumn 100, Issue 3, 1997, Pages 639-648

  Pawlowski, John E ^a,c   Taylor, David S ^a   Valentine, Maria ^a   Hail, Mark E ^a   Ferrer, Patricia ^a   Kowala, Mark C ^a   Molloy, Christopher J ^a,b  

^a BRISTOL MYERS SQUIBB   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^c AMGEN INC   (United States)

Author keywords

Atherosclerosis; EGF; Remodeling; Restenosis; TGF

Indexed keywords

ACTIVIN A; ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUTRALIZING ANTIBODY; THROMBIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; RESTENOSIS; VASCULAR SMOOTH MUSCLE;

EID: 0030756248     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119575     Document Type: Article

References (64)

1. Scott-Burden, T., T.J. Resink, A.W.A. Hahn, and P.M. Vanhoutte. 1991. Induction of endothelin secretion by angiotensin II: effects on growth and synthetic activity of vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 17: S96-S100.
2. Powell, J.S., M. Rouge, R.K.M. Müller, and H.R. Baumgartner. 1991. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells. Basic Res. Cardiol. 86(Suppl.):65-74.
3. Weber, H., M.L. Webb, R. Serafino, D.S. Taylor, S. Moreland, J. Norman, and C.J. Molloy. 1994. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol. Endocrinol. 8:148-158.
4. Huang, C.-L., and H. E. Ives. 1987. Growth inhibition by protein kinase C late in mitogenesis. Nature (Lond.). 329:849-850.
5. Herbert, J.M., I. Lamarch, and F. Dol. 1992. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor: effect of heparin. FEBS Lett. 301:155-158.
6. McNamara, C.A., I.J. Sarembock, L.W. Gimple, J.W. Fenton II, S.R. Coughlin, and G.K. Owens. 1993. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91:94-98.
7. Scott-Burden, T., A.W.A. Hahn, T.J. Resink, and F.R. Buhler. 1990. Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 16:S36-S41.
8. Sharifi, B.G., D.W. LaFleur, C.J. Pirola, J.S. Forrester, and J.A. Fagin. 1992. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J. Biol. Chem. 267:23910-23915.
9. Bailey, W.L., D.W. LaFleur, J.S. Forrester, J.A. Fagin, and B.G. Sharifi. 1994. Stimulation of rat vascular smooth muscle cell glycosaminoglycan production by angiotensin II. Atherosclerosis. 111:55-64.
10. Carney, D.H., R. Mann, W.R. Redin, S.D. Pernia, D. Berry, J.P. Heggers, P.G. Hayward, M.C. Robson, J. Christie, C. Annable, et al. 1992. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J. Clin. Invest. 89:1469-1477.
11. Sung, C.-P., A.J. Arleth, B.L. Storer, and E.H. Ohlstein. 1994. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J. Pharmacol. Exp. Ther. 271:429-437.
12. Coughlin, S. 1994. Thrombin receptor function and cardiovascular disease. Trends Cardiovasc. Med. 4:77-83.
13. Rogers, T.B., and A.J. Lokuta. 1994. Angiotensin II signal transduction pathways in the cardiovascular system. Trends Cardiovasc. Med. 4:110-116.
14. Berk, B.C., M.B. Taubman, E.J. Cragoe, Jr., J.W. Fenton II, and K.K. Griendling. 1990. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells: calcium and protein kinase C-dependent and -independent pathways. J. Biol. Chem. 265:17334-17340.
15. Duff, J.L., M.B. Marrero, W.G. Paxton, B. Schieffer, K.E. Bernstein, and B.C. Berk. 1995. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovasc. Res. 30:530-536.
16. Van Obberghen-Schilling, E., and J. Pouyssegur. 1993. Signaling pathways of the thrombin receptor. Thromb. Haemostasis. 70:163-167.
17. Weber, H., D.S. Taylor, and C.J. Molloy. 1994. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells: correlation with the expression of specific endogenous growth factors and reversal by suramin. J. Clin. Invest. 93:788-798.
18. Molloy, C.J., J.E. Pawlowski, D.S. Taylor, C.E. Turner, H. Weber, M. Peluso, and S.M. Seiler. 1996. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G protein-coupled receptor agonists. J. Clin. Invest. 97:1173-1183.
19. Naftilan, A.J., R.E. Pratt, and V.J. Dzau. 1989. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1419-1424.
20. Stouffer, G.A., I.J. Sarembock, C.A. McNamara, L.W. Gimple, and G.K. Owens. 1993. Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am. J. Physiol. 265:C806-C811.
21. Kanthou, C., O. Benzakour, G. Patel, J. Deadman, V.V. Kakkar, and F. Lupu. 1995. Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells. Thromb. Haemostasis. 74:1340-1347.
22. Weiss, R.H., and M. Maduri. 1993. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J. Biol. Chem. 268:5724-5727.
23. Itoh, H., M. Mukoyama, R.E. Pratt, G.H. Gibbons, and V.J. Dzau. 1993. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91:2268-2274.
24. Delafontaine, P., A. Anwar, H. Lou, and L. Ku. 1996. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor 1 receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J. Clin. Invest. 97:139-145.
25. Serruys, P.W., H.J.-P.R. Herrman, R. Simon, W. Rutsch, C. Bode, G.-J. Laarman, R. van Dijk, A.A. van den Bos, V.A.W.M. Umans, K.A.A. Fox, et al. 1995. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N. Engl. J. Med. 333:757-763.
26. Heyndrickx, G.R. 1993. Angiotensin-converting enzyme inhibitor in a human model of restenosis. Basic Res. Cardiol. 88 (Suppl.):169-182.
27. Giachelli, C., N. Bae, D. Lombardi, M. Majesky, and S. Schwartz. 1991. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem. Biophys. Res. Commun. 177:867-873.
28. Molloy, C.J., D.S. Taylor, and H. Weber. 1993. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268:7338-7345.
29. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
30. Esch, F.S., S. Shimasaki, K. Cooksey, M. Mercado, A.J. Mason, S.-Y. Ying, N. Ueno, and N. Ling. 1987. Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins. Mol. Endocrinol. 1:388-396.
31. Woodruff, T.K., H. Meunier, P.B.C. Jones, A.J.W. Hsueh, and K.E. Mayo. 1987. Rat Inhibin: molecular cloning of α-and β-subunit complementary deoxyribonucleic acids and expression in the ovary. Mol. Endocrinol. 1:561-568.
32. Ferrer, P., M. Valentine, T. Jenkins-West, H. Weber, N.L. Goller, S.K. Durham, C.J. Molloy, and S. Moreland. 1995. Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries. J. Cardiovasc. Pharmacol. 26:908-915.
33. Vale, W., A. Hsueh, C. Rivier, and J. Yu. 1990. The inhibin/activin family of hormones and growth factors. In Peptide Growth Factors and Their Receptors II. M.B. Sporn and A.B. Roberts, editors. Springer-Verlag New York Inc., New York. 95:211-248.
34. Ying, S.Y. 1988. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr. Rev. 9:267-293.
35. Petraglia, F., P.E. Sawchenko, A.T.W. Lim, G. Rivier, and W. Vale. 1987. Localization, secretion, and action of inhibin in human placenta. Science (Wash. DC). 237:187-189.
36. Inoue, S., A. Orimo, T. Hosoi, A. Ikegami, K. Kozaki, Y. Ouchi, S. Nomura, M. Muramatsu, and H. Orimo. 1994. Demonstration of activin-A in arteriosclerotic lesions. Biochem. Biophys. Res. Commun. 205:441-448.
37. Kozaki, K., Y. Ouchi, M. Akishita, M. Eto, K. Toba, K. Nagano, S. Inoue, M. Ishikawa, M. Hashimoto, T. Kodama, et al. 1995. Demonstration of the expression of activin-A and follistatin in atherosclerotic lesions: their role in foam cell formation of THP-1 macrophage in vitro. Circulation. 92:I-160.
38. Yu, J., L. Shao, V. Lemas, A.L. Yu, J. Vaughn, J. Rivier, and W. Vale. 1987. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature (Lond.). 330:765-767.
39. Smith, J.C., B.M.J. Price, K. van Nimmen, and D. Huylebroeck. 1990. Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature (Lond.). 345:729-731.
40. van den Eijnden-van Raaij, A.J.M., E.J.J. van Zoelen, K. van Nimen, C.H. Koster, G.T. Snoek, A.J. Durston, and D. Huylebroeck. 1990. Activin-like factor from a Xenopus laevis cell line responsible for mesoderm induction. Nature (Lond). 345:732-735.
41. Kojima, I., H. Mogami, N. Kawamura, H. Yasuda, and H. Shibata. 1993. Modulation of growth of vascular smooth muscle cells by activin A. Exp. Cell Res. 206:152-156.
42. Sakurai, T., Y. Abe, Y. Kasuya, N. Takuwa, R. Shiba, T. Yamashita, T. Endo, and K. Goto. 1994. Activin A stimulates mitogenesis in Swiss 3T3 fibroblasts without activation of mitogen-activated protein kinases. J. Biol. Chem. 269:14118-14122.
43. Kotajima, A., Y. Miyamoto, M. Tsuruo, M. Kosaka, and S. Saito. 1995. Effects of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells. Endocrinology. 136:1214-1218.
44. Hashimoto, M., A. Shoda, S. Inoue, R. Yamada, T. Kondo, T. Sakurai, N. Ueno, and M. Muramatsu. 1992. Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J. Biol. Chem. 267:4999-5004.
45. Hakovirta, H., A. Kaipia, O. Söder, and M. Parvinen. 1993. Effects of activin-A, inhibin-A, and transforming growth factor-β1 on stage-specific deoxyribonucleic acid synthesis during rat seminiferous epithelial cycle. Endocrinology. 133:1664-1668.
46. Sambhi, M.P., N. Swaminathan, H. Wang, and H. Rong. 1992. Increased EGF binding and EGFR mRNA expression in rat aorta with chronic administration of pressor angiotensin II. Biochem. Med. Metab. Biol. 48:8-18.
47. Rossi, M.J., N. Chegini, and B.J. Masterson. 1992. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology. 130:1716-1727.
48. Temizer, D.H., M. Yoshizumi, M.A. Perrella, E.E. Susanni, T. Quertermous, and M.-E. Lee. 1992. Induction of heparin-binding EGF-Iike growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 267:24892-24896.
49. Miyagawa, J., S. Higashiyama, S. Kawata, Y. Inui, S. Tamura, K. Yamamoto, M. Nishida, T. Nakamura, S. Yamashita, Y. Matsuzawa, and N. Taniguchi. 1995. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 95:404-411.
50. Petraglia, F., P. Sacerdote, A. Cossarizza, S. Angioni, A.D. Genazzani, C. Franceschi, M. Muscettola, and G. Grasso. 1991. Inhibin and activin modulate human monocyte chemotaxis and lymphocyte interferon-γ production. J. Clin. Endocrinol. Metab. 72:496-502.
51. Nishihara, T., N. Okahashi, and N. Ueda. 1993. Activin A induces apoptotic cell death. Biochem. Biophys. Res. Commun. 197:985-991.
52. 3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro. Mol. Cell. Endocrinol. 61:133-138.
53. Yasuda, H., T. Mine, H. Shibata, Y. Eto, Y. Hasegawa, T. Takeuchi, S. Asano, and I. Kojima. 1993. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J. Clin. Invest. 92:1491-1496.
54. McCarthy, S.A., and R. Bicknell. 1993. Inhibition of vascular endothelial cell growth by activin-A. J. Biol. Chem. 268:23066-23071.
55. Bennett, M.R., G.I. Evan, and S.M. Schwartz. 1995. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ. Res. 77:266-273.
56. Bennett, M.R., G.I. Evan, and S.M. Schwartz. 1995. Apoptosis of human coronary vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J. Clin. Invest. 95:2266-2274.
57. Border, W.A., and E. Ruoslahti. 1992. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
58. Roberts, A.B., B.K. McCune, and M.B. Sporn. 1992. TGF-β: regulation of extracellular matrix. Kidney Int. 41:557-559.
59. Wolf, Y.G., L.M. Rasmussen, and E. Ruoslahti. 1994. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J. Clin. Invest. 93:1172-1178.
60. Massagué, J. 1987. The TGF-β family of growth and differentiation factors. Cell. 49:437-438.
61. Roberts, A.B., M.B. Sporn, R.K. Assoian, J.M. Smith, N.S. Roche, L.M. Wakefield, U.I. Heine, L.A. Liotta, V. Falanga, J.H. Kehrl, and A.S. Fauci. 1986. Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA. 83:4167-4171.
62. Roberts, A.B. 1995. Transforming growth factor-β: activity and efficacy in animal models of wound healing. Wound Repair Regen. 3:408-418.
63. Matsuse, T., A. Ikegami, E. Ohga, T. Hosoi, T. Ika, K. Kida, F. Masashi, S. Inoue, T. Nagase, Y. Ouchi, and Y. Fukuchi. 1996. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am. J. Pathol. 148:707-713.
64. Hübner, G., Q. Hu, H. Smola, and S. Werner. 1996. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev. Biol. 173:490-498.